Advertisement

Topics

Dr. Reddy's Labs: FDA Approves TOSYMRA Nasal Spray For Migraine

00:28 EST 28 Jan 2019 | FinanzNachrichten

NEW DELHI (dpa-AFX) - Dr. Reddy's Laboratories Ltd. (RDY, DRREDDY) and its subsidiary, Promius Pharma, LLC announced late Sunday the approval of TOSYMRA, previously known as DFN-02, by the U.S. Fo...

Original Article: Dr. Reddy's Labs: FDA Approves TOSYMRA Nasal Spray For Migraine

NEXT ARTICLE

More From BioPortfolio on "Dr. Reddy's Labs: FDA Approves TOSYMRA Nasal Spray For Migraine"

Advertisement
Quick Search
Advertisement
Advertisement